ARCHIVES

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Iressa Authorization In Europe Clarifies Differences Between U.S., E.U. Standards

July 31, 2009

DCT Board Approves Concepts For Acoustic Microscopy, Taxol Development, AIDS R&D

June 15, 1990

Oxford University Press Wins CRADA For Journal Of The National Cancer Istitute

September 20, 1996

NCI, NINCDS Need Patients For Brain, Breast Studies

September 10, 1982

NCI Names 15 to Director’s Consumer Liaison Group.

January 14, 2005

Epstein Back With New Attack On “Establishment” In Congressional Record

November 6, 1987